Skip to content

Research on the Tumor Microenvironment and Target Discovery in Liver Metastasis

Research on the Tumor Microenvironment and Target Discovery in Liver Metastasis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127248
Enrollment
Unknown
Registered
2026-06-28
Start date
2026-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digestive system tumors with liver metastasis

Interventions

Hepatic metastatic tumor:None

Sponsors

The First Hospital of Jiaxing
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged >= 18 years; 2. Pathologically confirmed primary gastrointestinal tumor with liver metastasis; 3. Able to provide residual tissue samples from surgery or biopsy, as well as blood samples; 4. Capable of understanding the study information and able to sign an informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe dysfunction of vital organs such as the heart, lungs, or kidneys; 2. Pregnant or breastfeeding women; 3. Patients who have previously received targeted immunotherapy or experimental interventions for liver metastases; 4. Individuals unable to comply with follow-up or those with mental disorders affecting informed consent.

Design outcomes

Primary

MeasureTime frame
Expression levels and spatial distribution of liver metastasis-specific targets;

Secondary

MeasureTime frame
Immune cell infiltration levels and spatial interaction network characteristics.;Therapeutic efficacy?related metrics in PDO/PDX and co?culture models, including cytotoxicity, cytokine secretion, persistence, and exhaustion phenotype dynamics.;

Countries

China

Contacts

Public ContactSong Binbin

The First Hospital of Jiaxing

15024363171@163.com+86 15024363171

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 3, 2026